Photodynamic therapy in ocular vascular disease

IEEE Journal on Selected Topics in Quantum Electronics

Volumn 2, Issue 4, 1996, Pages 988-996

  Schmidt Erfurth, Ursula ^a   Birngruber, Reginald ^b   Hasan, Tayyaba ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b MEDICAL LASER CENTER LÜBECK   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; LASER SURGERY; OPHTHALMOLOGY; PATIENT TREATMENT; PHOTOSENSITIVITY;

LOW DENSITY LIPOPROTEIN; OCULAR VASCULAR DISEASE; PHOTODYNAMIC VASOOCCLUSION; PHOTOSENSITIZERS;

PHOTODYNAMIC THERAPY;

EID: 0030370806     PISSN: 1077260X     EISSN: None     Source Type: Journal    
DOI: 10.1109/2944.577328     Document Type: Article

References (58)

1. R. L. Lipson, E. J. Baldes, and A. M. Olsen, "Further evolution of the use of hemaloporphyrin derivative as a new aid for the endoscopic detection of malignant disease," Dis. Chest, vol. 46, pp. 676-679, 1964.
2. I. Diamond, S. G. Granelli, A. F. McDonagh, S. Nielsen, C. B. Wilson, and R. Jaeniche, "Photodynamic therapy of malignant tumors," Lancet, pp. 1175-1177, 1972.
3. T. J. Dougherty, W. Potter, and D. Belnier, "Photodynamic therapy for the treatment of cancer: Current status and advances," in Photodynamic Therapy of Neoplastic Disease, D. Kessel, Ed. Boca Raton, FL: CRC, 1989.
4. K. Weishaupt, C. J. Gomer, and T. Dougherty, "Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor," Cancer Res., vol. 36, pp. 2326-2329, 1976.
5. A. Castellani, G. P. Pace, and M. Concioli, "Photodynamic effect of hematoporphyrin on blood microcirculation," J. Pathol. Bacteriol., vol. 86, pp. 99-102, 1963.
6. P. J. Bugelski, C. W. Porter, and T. J. Dougherty, "Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse," Cancer Res., vol. 41, pp. 4060-4612, 1981.
7. W. M. Star, J. P. A. Marijnissen, A. van den Berg-Blok, and H. S. Reinhold, "Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers," Cancer Res., vol. 46, pp. 2532-2540, 1986.
8. R. A. Bruce, Jr., "Evaluation of hematoporphyrin photoradiation therapy techniques in the treatment of intraocular tumors," Photochem. Photobiol., vol. 46, pp. 919-923, 1987.
9. D. T. Tse, J. J. Dutton, T. A. Weingeist et al., "Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma," Arch. Ophthalmology, vol. 102, pp. 833-838, 1989.
10. A. L. Murphree, M. Cote, and C. J. Gomer, "The evolution of photodynamic therapy in the treatment of intraocular tumors," Photochem. Photobiol., vol. 46, pp. 919-923, 1987.
11. G. L. Zahler, M. Poh, P. Fitz, D. L. Krohn, R. Jacobs, and L. B. Harber, "Induction of drug photosensitization in man after parental exposure to hematoporphyrin," Arch. Dermatol., vol. 116, pp. 1392-1397, 1977.
12. C. J. Byrne, L. V. Marshal, and A. D. Ward, "The structure of the active material in hematoporphyrin derivative," Photochem. Photobiol., vol. 46, pp. 575-580, 1987.
13. S. Kimel, B. J. Tromberg, W. G. Roberts, and M. W. Berns, "Singlet oxygen generation of porphyrins, chlorins and phthalocyanines," Photochem. Photobiol., vol. 50, pp. 175-183, 1989.
14. E. Glassberg, L. Lewandowski, G. Lask, and J. Vitto, "Laser induced photodynamic therapy with aluminum, phthalocyanine tetrasulfonate as the photosensitizer," J. Invest. Dermatol., vol. 94, pp. 604-610, 1990.
15. W. G. Roberts, Y. Shiau, J. S. Nelson, K. M. Smith, and M. W. Berns, "In vitro characterization of monoaspartylchlorin e6 and diaspartylchlorin e6 for photodynamic therapy," J. Nat. Cancer Inst., vol. 80, pp. 330-336, 1988.
16. J. S. Nelson, W. G. Roberts, and M. W. Berns, "In vivo studies on the utilization of monoaspartylchlorin for photodynamic therapy," Cancer Res., vol. 47, pp. 4681-4685, 1987.
17. R. Bachor, C. R. Shea, R. Gillies, and T. Hasan, "Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres," in Proc. Nat. Acad. Sci., 1991, vol. 88, pp. 1580-1584.
18. A. M. Richter, S. Cerruti-Sola, E. Sternberg, D. Dolphin, and J. G. Levy, "Biodistribution of tritiated benzoporphyrin derivative, a new potent photosensitizer in normal and tumor-bearing mice," J. Photocem. Photobiol., vol. B5, pp. 231-244, 1990.
19. B. Aveline, T. Hasan, and R. W. Redmond, "Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA)," Photochem. and Photobiol., vol. 59, pp. 328-335, 1994.
20. H. Lui, N. Kollias, J. Wimberly, L. Hruza, and R. Anderson, "Photodynamic therapy of malignant skin tumours with BPD-MA," Laser Dermatol. Plast. Surg., SPIE, vol. B 1876, p. 37, 1993.
21. D. Mew, V. Lum, C. K. Wat, G. H. Towers, and J. G. Levy, "Ability of specific monoclonal antibodies and antisera conjugated hemtoporphyrin to label and kill selective cell lines subsequent to light activation," Cancer Res., vol. 45, pp. 4380-4386, 1985.
22. T. Hasan, "Targeting of cancer cells with molecular delivery systems," in Proc. SPIE, 1993, vol. 1203, pp. 1136-1143.
23. B. A. Goff, M. Bamberg, and T. Hasan, "Photoimmunotherapy of human ovarian carcinoma cells ex vivo," Cancer Res., vol. 51, pp. 4762-4767, 1991.
24. A. Barel, G. Jori, A. Perrien, P. Romanchini, A. Pagnan, and S. Bifanti, "Role of high-, low- and very low-density lipoproteins in the transport and tumor delivery of hematoporphyrin in vivo," Cancer Lett., vol. 32, p. 145, 1986.
25. G. Jori, M. Beltramini, E. Reddi, A. Pagnan, L. Tomio, and T. Tsanov, "Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo," Cancer Lett., vol. 24, p. 291, 1984.
26. J. L. Goldstein, R. G. W. Anderson, and M. S. Brown, "Coated pits, vesicles and receptor mediated endocytosis," Nature, vol. 179, p. 679, 1979.
27. D. Gal, P. C. McDonald, J. C. Porter, and E. R. Simpson, "Cholesterol metabolism in cancer cells in monolayer culture," Int. J. Cancer, vol. 28, pp. 315-319, 1981.
28. C. L. Shields, J. A. Shields, and P. de Potter, "Plaque radiotherapy in the management of retinoblatoma," Ophthalmol., vol. 100, pp. 216-224, 1993.
29. T. W. Sery, "Photodynamic killing of retinoblastoma cells with hematoporphyrin derivative and light," Cancer Res., vol. 39, pp. 96-100, 1979.
30. J. Winther, "Effect of photofrin II and light energy on retinoblastoma-like cells in vitro," J. Cancer Res. Clin. Oncol., vol. 115, pp. 73-78, 1989.
31. U. Schmidt-Erfurth, H. Diddens, R. Birngruber, and T. Hasan, "Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates," Br. J. Cancer, 1996.
32. S. Vitols, G. Gahrton, M. Björkhol, and C. Peterson, "Hypocholes-terolemia in malignancy due to elevated LDL-receptor activity in tumor cells," Lancet, vol. 2, pp. 1150-1154, 1985.
33. M. J. Rudling, B. Angeli, C. O. Peterson, and V. P. Collins, "Low-density lipoprotein receptor activity in human intracranial tumors and its relation to the cholesterol requirement," Cancer Res., vol. 50, pp. 483-487, 1990.
34. B. W. Henderson and V. H. Fingar, "Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model," Photochem. Photobiol., vol. 49, pp. 299-304, 1989.
35. C. Zhou, C. Milanesi, and G. Jori, "An ultrastructural comparative evaluation of tumors photosensitized by porphyrins administered in aqueous solution to liposomes or to lipoproteins," Photochem. Photobiol., vol. 48, p. 487, 1988.
36. N. Simionescu and M. Simionescu, "Cellular interactions of lipoproteins with the vascular endothelium: Endocytosis and transcytosis," Targeted Diagn, Ther., vol. 5, pp. 45-55, 1991.
37. M. R. Hamblin and E. L. Newman, "Photosensitizer targeting in photodynamic therapy. II. Conjugates of hematoporphyrin with serum lipoproteins," J. Photochem. Photobiol., vol. B26, pp. 147-157, 1994.
38. H. S. N. Greene, "A spontaneous melanoma in the hamster with a propensity for amelanotic alteration and sarcomatous transformation during transplantation," Cancer Res., vol. 18, pp. 422-425, 1958.
39. L. E. Zimmerman and I. W. McLean, "An evaluation of enucleation in the management of uveal melanomas," Amer. J. Ophthalmol., vol. 87, pp. 741-760, 1979.
40. P. K. Lommatzsch, "Results after ß- irradiation of choroidal melanomas: 20 years experience," Br. J. Ophthalmol., vol. 70, pp. 844-851, 1986.
41. T. W. Sery, J. A. Shields, J. J. Augsburger, and H. G. Shah, "Photodynamic therapy of human ocular cancer," Ophthalmic Surg., vol. 18, pp. 413-418, 1987.
42. R. A. Lewis, D. T. Tse, C. D. Phelps, and T. A. Weingeist, "Neovascular glaucoma after photoradiation therapy for uveal melanoma," Arch. Ophthalmol., vol. 102, pp. 839-842, 1984.
43. U. Schmidt-Erfurth, W. Bauman, E. Gragoudas, T. J. Flotte, N. A. Michaud, R. Birngruber, and T. Hasan, "Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin," Ophthalmol., vol. 101, pp. 89-99, 1994.
44. A. M. Richter, B. Kelly, J. Chow, D. J. Liu, G. H. M. Towers, D. Dolphin, and J. G. Levy, "Preliminary studies on a more effective phototoxic agent than hematoporphyrin," J. Nat. Cancer Inst., vol. 79, pp. 1320-1332, 1987.
45. A. M. Richter, S. Cerruti-Sola, E. Sternberg, D. Dolphin, and J. G. Levy, "Biodistribution of tritiated benzoporphyrin derivative, a new potent photosensitizer in normal and tumor-bearing mice," J. Photochem. Photobiol., vol. B5, pp. 231-244, 1990.
46. T. W. Sery and T. J. Dougherty, "Photoradiation of rabbit ocular malignant melanoma sensitized with hematoporphyrin," Curr. Eye Res., vol. 3, pp. 519-528, 1984.
47. I. Vlodavsky, P. E. Fielding, C. J. Fielding, and D. Gospodarowicz, "Role of contact inhibition in the regulation of receptor mediated uptake of low-density lipoprotein in culture vascular endothelial cells," in Proc. Nat. Acad. Sci., U.S.A., 1978, vol. 75, pp. 356-360.
48. C. J. Gomer, N. Rucker, and A. L. Murphree, "Differential cell photosensitivity following porphyrin photodynamic therapy," Cancer Res., vol. 48, pp. 4539-4542, 1988.
49. L. G. Hyman, A. M. Lilienfeld, F. L. Ferris, and S. L. Fine, "Senile macular degeneration: A case control study," Am. J. Epidemiol., vol. 118, pp. 213-227, 1983.
50. U. Schmidt-Erfurth, T. Hasan, E. Gragoudas, N. Michaud, T. J. Flotte, and R. Birngruber, "Vascular targeting in photodynamic occlusion of subretinal vessels," Ophthalmol., vol. 101, pp. 1953-1961, 1994.
51. V. H. Fingar, T. J. Wieman, and K. W. Doak, "Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction," Cancer Res., vol. 50, pp. 2599-2603, 1990.
52. B. A. Allison, E. Waterfield, A. M. Richter, and J. G. Levy, "The effects of plasma lipoproteins on in vitro tumor cell kill and in vivo tumor photosensitization with benzoporphyrin derivative," Photochem. Photobiol., vol. 54, pp. 709-715, 1991.
53. T. Okunaka, M. C. Eckhauser, and H. Kato, "Correlation between photodynamic efficacy of different porphyrins and membrane partitioning behavior," Lasers Surg. Med., vol. 12, pp. 98-103, 1992.
54. K. C. Hayes, S. Lindsay, Z. F. Stephan, and D. Brecker, "Retinal pigment epithelium possesses both LDL and scavenger receptor activity," Invest. Ophthalmol. Vis. Sci., vol. 30, pp. 225-232, 1989.
55. M. Matsumoto, T. Miki, A. Obana, K. Shiraki, and T. Sakamoto, "Choroidal damage in dye enhanced photocoagulation," Lasers and Light in Ophthalmol., vol. 5, pp. 157-165, 1993.
56. D. Husain, J. W. Miller, N. Michaud, P. J. Flotte, M. Kramer, and E. Gragoudas, "Long term effect of photodynamic therapy using liposomal benzoporphyrin derivative on experimental choroidal neovascularization and normal retina and choroid," Invest. Ophthalmol. Vis. Sci., vol. 37, pp. S223, 1996.
57. U. Schmidt-Erfurth, J. W. Miller, M. Sickenberg, A. Strong, U. Hoehne, M Fsadni, R. Birngruber, H. van den Bergh, H. Lagna, E. Gragoudas, L. Zografos, and N. Bressler, "Photodynamic therapy of subfoveal choroidal neovascularization using benzoporphyrin derivative: First results of a multicenter trial," Invest. Ophthalmol. Vis. Sci., vol. 37, p. S122, 1996.
58. J. W. Miller, U. Schmidt-Erfurth, M. Sickenberg, E. S. Gragoudas, N. M. Bressler, H. A. Strong, U. Hoehne, M. Fsadni, A. M. Lane, H. van den Bergh, H. Lagna, L. Zografos, and B. Piguet, "Selected angiographic findings following photodynamic therapy of subfoveal choroidal neovascularization," Invest. Ophthalmol. Vis. Sci., vol. 37, p. S223, 1996.